Skip to content

Mentions in the Press

Highlighting Our Clients' Media Coverage

See how our clients are making headlines with impactful stories and expert insights featured in top-tier media outlets.

Why Having a Dog Is So Good for Your Mental Health (Scientifically Speaking)

Read Now

New Study Looks at How the Brain Changes During Pregnancy and It’s Incredible

Read Now

Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal

Read Now

Enveric inks $62M licensing deal for psilocin prodrug

Read Now

Stealth mode biotech startups: Everything you need to know

Read Now

Enveric Biosciences Presents Compelling Preclinical Data On Lead Compound EB-003 At 7th Neuropsychiatric Drug Summit

Read Now

Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences’ Breakthrough Research

Read Now

The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now?

Read Now

Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally

Read Now

Enveric Biosciences Announces Promising Preclinical Results for EB-003

Read Now